Catalyst Wire Dossier Catalyst Wire Dossier

NN1250 formulation A

NN1250 · Novo Nordisk A/S
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NN1250 formulation A, covering 2015-11-16 to 2015-11-16. Get the full timeline:

Most recent: Clinical Trial Update: Comparison of Two NN1250 Formulations Versus Insulin Glargine, All in Combination With Metformin in Subjects With Type 2 Diabetes [Phase 2]

See pricing